HIGHLIGHTS
- who: Tarsha Jones from the Our study design is a qualitative study with clinical encounters of providers and their high-risk patientsThe clinical encounter data was captured from providers enrolled in a pilot study that was conducted prior to implementing the RCT [15], the same providers were also enrolled in our main randomized controlled trial that was recently published [16]. Participants were eligible to participate in the RCT if they were high-risk women, with a, year invasive breast cancer risk u2265, .67% according to the Gail model or personal history of lobular carcinoma in situ (LCIS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.